ethyl 2-oxo-2-[3-(trifluoromethyl)anilino]acetate,
17738-86-2,
ethyl {[3-(trifluoromethyl)phenyl]carbamoyl}formate,
ethyl oxo{[3-(trifluoromethyl)phenyl]amino}acetate,
Q-103474,
ethyl 2-oxo-2-((3-(trifluoromethyl)phenyl)amino)acetate,
ethyl 3'-(trifluoromethyl)oxanilate,
AC1LXQGN,
SCHEMBL596433,
CTK6F3471,
KS-00001UDX,
DTXSID80365200,
UKPJCBWVGQNZSF-UHFFFAOYSA-N,
BCP23237,
ZINC2156711,
ZX-AP012930,
9310AA,
ANW-66576,
MFCD00111794,
SBB102400,
STK297075,
AKOS000344226,
MCULE-4558879007,
ACM17738862,
SEL10319706,
AJ-33688,
AX8162509,
TC-155321,
AM20030173,
FT-0732767,
2F-081,
EN300-235733,
Ethyl oxo{[3-(trifluoromethyl)-phenyl]amino}acetate,
I01-1501,
ethyl {N-[3-(trifluoromethyl)phenyl]carbamoyl}formate,
ethyl 2-oxo-2-(3-(trifluoromethyl)phenylamino)acetate,
ethyl 2-oxo-2-(3-trifluoromethylphenylamino)-acetate,
Z56755840,
F0835-0044,
ethyl 2-oxo-2-((3-(trifluoromethyl)phenyl)amino)acet ate,
2-[3-(Trifluoromethyl)phenylamino]glyoxylic acid ethyl ester,
5-hydroxyisophthalamide;ethyl {[3-(trifluoroMethyl)phenyl]carbaMoyl}forMate,
C11H10F3NO3,
ZINC02156711,
CID1805242,